Charles Schwab Investment Management Inc. Has $33.94 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

Charles Schwab Investment Management Inc. grew its position in Oscar Health, Inc. (NYSE:OSCR) by 20.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,600,166 shares of the company’s stock after purchasing an additional 270,223 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Oscar Health were worth $33,940,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in OSCR. Simplicity Wealth LLC acquired a new position in shares of Oscar Health in the second quarter valued at approximately $179,000. SG Americas Securities LLC boosted its stake in shares of Oscar Health by 900.6% in the second quarter. SG Americas Securities LLC now owns 190,039 shares of the company’s stock valued at $3,006,000 after buying an additional 171,047 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after buying an additional 507,009 shares during the period. Raymond James & Associates bought a new stake in shares of Oscar Health in the second quarter valued at approximately $3,168,000. Finally, Hennessy Advisors Inc. bought a new stake in shares of Oscar Health in the second quarter valued at approximately $9,047,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Performance

NYSE OSCR opened at $17.99 on Wednesday. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of -299.78 and a beta of 1.63. Oscar Health, Inc. has a twelve month low of $7.50 and a twelve month high of $23.79. The stock has a fifty day simple moving average of $17.25 and a 200 day simple moving average of $17.97. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.29) earnings per share. Sell-side analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was purchased at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the acquisition, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the acquisition, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 150,360 shares worth $2,645,074. 25.11% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on OSCR shares. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. Finally, Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.